Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-26

Clinical Trial Update: Red Blood Cell Transfusion Thresholds and QOL in MDS [NA]

View source ↗

Summary

Clinical trial update examining red blood cell transfusion thresholds and quality of life in patients with myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Myelodysplastic Syndromes (MDS), Quality of Life | NA | Status: UNKNOWN